CSL Partners With AWS for AI Drug Research
Australian biotechnology firm CSL is collaborating with Amazon Web Services to integrate artificial intelligence into its research and clinical development pipeline. The partnership aims to accelerate drug discovery timelines and streamline data management processes.
Insights:
Australia's CSL tapped Amazon's cloud unit on Tuesday morning to harness artificial intelligence across its research and clinical development pipeline. The biotechnology firm announced the partnership to accelerate drug discovery timelines. The collaboration follows recent pricing agreements with the United States government.
